+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Metabolomics Technology Market Research and Forecast, 2019-2025

  • ID: 4766746
  • Report
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • AB SCIEX, LLC
  • Bruker Corp.
  • Evotec AG
  • LECO Corp.
  • metaSysX GmbH
  • Shimadzu Corp.
  • MORE
Global Metabolomics Technology Market Size, Share & Trends Analysis Report by Products and Services (Metabolomics Instruments and Metabolomics Bioinformatics), by Application (Drug Discovery, Biomarkers, Toxicology, and Personalized Medicine), and Forecast, 2019-2025.

Metabolomics is referred to as the systematic learning of chemical procedures including metabolites. It is the study of the single biochemical impressions that is left behind by the detailed cellular methods. Increasing demand for personalized medicine, rising funding for the research in cancer and CVD, application of metabolomics in toxicology are the major factors that are contributing to the growth of the market. Moreover, the technological advancement in the metabolomics technology for a different indication such as cancer and inborn errors of metabolism further boost the growth of metabolomics technology market. However, certain factors such as lack of skilled professionals and high cost of instruments serve as the key barriers in the metabolomics technology market.

Geographically, the global metabolomics technology market is analyzed into North America, Europe, Asia-Pacific and Rest of the World. The metabolomics market in North America is estimated to have a significant market share due to the presence of major market players such as Agilent Technologies, Inc., Thermo Fisher Scientific Inc. coupled with the investments made by these players are contributing to the growth of the market. Moreover, increasing research on biomarkers and personalized medicine in the region is augmenting the market growth. Further, the Asia-Pacific has a significant growth in the metabolomics market owing to the increasing prevalence of CVD and increasing awareness towards the diagnosis of these diseases.

Moreover, the global metabolomics market is influenced by product development and technological advancements conducted by the market players. The key players of the metabolomics technology include Agilent Technologies Inc., Metabolon Inc., LECO Corp., Bio-Rad Laboratories, Inc., Metabolomic Diagnostics Ltd., Metabolomic Technologies Inc., Metabolon, Inc., metaSysX GmbH, ONE WAY LIVER, S.L, and others

Research Methodology

The market study of global metabolomics technology market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic Databases Such as National Institute of Health
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended to life sciences instrumentation and reagent companies, clinical research institutes, metabolomics service providers, instrument manufacturers, and pharmaceutical, biopharmaceutical, and biotechnology companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and market growth opportunity. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Metabolomics Technology Market Research and Analysis, by Products & Services
2. Global Metabolomics Technology Market Research and Analysis, by Application

The Report Covers:
  • Comprehensive research methodology of the global metabolomics technology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global metabolomics technology market.
  • Insights about market determinants which are stimulating the global metabolomics technology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AB SCIEX, LLC
  • Bruker Corp.
  • Evotec AG
  • LECO Corp.
  • metaSysX GmbH
  • Shimadzu Corp.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Evotec AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. Swot Analysis
3.3.1.4. Recent Developments
3.3.2. Thermo Fisher Scientific Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. Swot Analysis
3.3.2.4. Recent Developments
3.3.3. Shimadzu Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. Swot Analysis
3.3.3.4. Recent Developments
3.3.4. Bio-Rad Laboratories, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. Swot Analysis
3.3.4.4. Recent Developments
3.3.5. Waters Corp.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. Swot Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Metabolomics Technology Market by Products and Services
5.1.1. Metabolomics Instruments
5.1.1.1. Chromatography
5.1.1.2. Mass Spectrometry
5.1.1.3. Nuclear Magnetic Resonance Spectroscopy
5.1.1.4. Others (Capillary Electrophoresis, Surface-Based Mass Analysis)
5.1.2. Metabolomics Bioinformatics
5.2. Global Metabolomics Technology Market by Application
5.2.1. Drug Discovery
5.2.2. Biomarkers
5.2.3. Toxicology
5.2.4. Personalized Medicine

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. AB SCIEX, LLC
7.2. Agilent Technologies Inc.
7.3. Biocrates Life Sciences AG
7.4. Bio-Rad Laboratories, Inc.
7.5. Bruker Corp.
7.6. Chenomx Inc.
7.7. Evotec AG
7.8. Giotto Biotech S.r.l.
7.9. Human Metabolome Technologies Inc.
7.10. LECO Corp.
7.11. Metabolomic Diagnostics Ltd.
7.12. Metabolomic Technologies Inc.
7.13. Metabolon, Inc.
7.14. metaSysX GmbH
7.15. ONE WAY LIVER, S.L
7.16. Shimadzu Corp.
7.17. SiDMAP, LLC
7.18. Stemina Biomarker Discovery, Inc.
7.19. Thermo Fisher Scientific Inc.
7.20. Waters Corp.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AB SCIEX, LLC
  • Agilent Technologies Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corp.
  • Chenomx Inc.
  • Evotec AG
  • Giotto Biotech S.r.l.
  • Human Metabolome Technologies Inc.
  • LECO Corp.
  • Metabolomic Diagnostics Ltd.
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • metaSysX GmbH
  • ONE WAY LIVER, S.L
  • Shimadzu Corp.
  • SiDMAP, LLC
  • Stemina Biomarker Discovery, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.1. AB SCIEX, LLC
  • Agilent Technologies Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corp.
  • Chenomx Inc.
  • Evotec AG
  • Giotto Biotech S.r.l.
  • Human Metabolome Technologies Inc.
  • LECO Corp.
  • Metabolomic Diagnostics Ltd.
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • metaSysX GmbH
  • ONE WAY LIVER, S.L
  • Shimadzu Corp.
  • SiDMAP, LLC
  • Stemina Biomarker Discovery, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
Note: Product cover images may vary from those shown
Adroll
adroll